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Objective: Subthreshold depression has a considerable impact on the
quality of life and carries a high risk of developing major depressive
disorder. Psychological treatments for subthreshold depression may be
able to reduce depressive symptomatology and prevent the onset of
major depression.
Method: We conducted a meta-analysis of randomized controlled
studies examining the eﬀects of psychological treatments for
subthreshold depression. We examined the eﬀects on depressive
symptoms and the preventive eﬀects on the incidence of major
depression.
Results: Seven high-quality studies with a total of 700 subjects were
included. The mean eﬀect size at post-test was 0.42 (95% CI: 0.23–
0.60), with very low heterogeneity. The relative risk of developing a
major depressive disorder in subjects who received the intervention was
0.70 (95% CI: 0.47–1.03; P ¼ 0.07).
Conclusion: Psychological treatments have signiﬁcant eﬀects on
subthreshold depression. Furthermore, these interventions may
prevent the onset of major depression.
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Summations
• Psychological interventions for patients with subthreshold depression have a signiﬁcant effect on
depressive symptomatology.
• On the longer term, these psychological interventions only have small effects on depressive
symptomatology.
• On the longer term, psychological interventions for patients with subthreshold depression may have
an effect on the incidence of major depressive disorders.
Considerations
• The number of studies examining the effects of psychological interventions for patients with
subthreshold depression is relatively small.
• The studies that have examined these effects used different deﬁnitions of subthreshold depression.
• Several other basic elements of included studies differ from each other, such as the target groups,
measures, and interventions.
Introduction
It is well established that subthreshold forms of
depression are not only highly prevalent (1, 2), but
also clinically relevant. Community studies that
have used DSM-IV criteria for minor depression
show prevalence rates ranging from 5% to 10% (2,
3). When subthreshold depression is deﬁned as
scoring above a cut-oﬀ score in self-rating depres-
sion scales, prevalence rates are much higher (4).
Subthreshold depression has been found to have
a considerable impact on the quality of life of
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patients (2, 5, 6) and results in increased utilization
of medical services (7). It is also associated with an
increased mortality rate (8, 9), is associated with
huge economic costs (10), and carries a high risk of
developing major depressive disorder in both the
short term (11) and the long term (12).
Subthreshold depression can be deﬁned from at
least three diﬀerent perspectives. In the ﬁrst
perspective, it is assumed that depressive sympto-
matology exists on a continuum with no symptoms
at one end, major depression at the other, and
subthreshold depression in between (3, 13–15).
There is indeed considerable empirical evidence
indicating that depression may best be conceptu-
alized as a continuum (13, 16, 17), although the
possibility of a latent qualitative diﬀerence between
clinical depression and subclinical depressive symp-
toms cannot be ruled out (14). In the second
perspective, subthreshold depression is considered
to be a condition with unique characteristics that
distinguish it categorically from other depressive
symptoms (18). The deﬁnition of minor depression
in the DSM-IV and other diagnostic classiﬁcation
systems such as the ICD-10 or the Research
Diagnostic Criteria, are examples of this approach.
In the third perspective, subthreshold depression is
regarded as a part of the prodomal phase of major
depression, or are residual symptoms in people
who have recently recovered from a major depres-
sion. All or nearly all subjects who develop major
depression can be assumed to have initially passed
through a period (however, brief) of subthreshold
depression. Although the ﬁrst two perspectives are
mutually exclusive, the third perspective does not
rule out the other perspectives.
From a clinical point of view, subthreshold
depression is important for two reasons. First, as
subthreshold depression is often an invalidating
condition with considerable psychological suﬀer-
ing, treatment is frequently necessary. The goal of
this treatment is to reduce depressive symptoma-
tology and to improve quality of life.
The second reason why subthreshold depression
is important from a clinical viewpoint, is the
increased risk of developing major depression. In
an earlier systematic review, we found that the
incidence rate of major depression in subjects with
subthreshold depression in community studies
ranges from 1 to 15 new cases per 100 person
years, compared with 0 to 5 in subjects without
subthreshold depression (11). In studies among
medical patients with subthreshold depression the
incidence rates range from 6 to 58 per 100 person
years, compared with 0 to 23 in subjects without
subthreshold depression (11). Virtually all of the
many studies that have examined the incidence
rates of major depression in subjects with sub-
threshold depression compared to those without,
conﬁrm that the incidence rate is greatly increased
in subthreshold depression. Because of this
increased risk of getting major depression, inter-
ventions in subthreshold depression are often
aimed at preventing the onset of major depression.
It is well established that psychological inter-
ventions are eﬀective in the treatment of depressive
disorders. In the past three decades, at least 160
controlled and comparative studies and more than
20 meta-analyses have examined the eﬀects of
psychological treatments (19) and this research has
clearly shown that most psychological treatments
studied in a trial have large eﬀects on depression.
However, no meta-analysis or systematic review
has examined the eﬀects of psychological interven-
tions on subthreshold depression. Therefore, we
decided to conduct such a meta-analytic review.
Aims of the study
In this systematic review, we examine the eﬀects of
psychological interventions aimed at subjects with
subthreshold depression. We focus exclusively on
studies in which subjects do have clinically relevant
depressive symptoms, but do not meet criteria for
major depressive disorder or dysthymia. We will
examine whether the interventions used in these
studies are capable of reducing depressive symp-
toms in subjects with subthreshold depression, but
we will also investigate whether these interventions
result in a reduced incidence of new cases of major
depressive disorder. As far as we know, no
systematic review in this area has been conducted
before now.
Material and methods
Identification and selection of studies
First, we used a large database of studies on the
psychological treatment of depression in general.
This database was developed through a compre-
hensive literature search (from 1966 to March
2006) in which we examined 4661 abstracts in
Pubmed (1127 abstracts), Psycinfo (1225), Embase
(925) and the Cochrane Central Register of Con-
trolled Trials (1384). We identiﬁed these abstracts
by combining terms indicative of psychological
treatment (psychotherapy, psychological treat-
ment, cognitive therapy, behaviour therapy, inter-
personal therapy, reminiscence, life review) and
depression (both MeSH-terms and textwords). For
this database, we also collected the primary studies
from 22 meta-analyses of psychological treatment
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of depression (19). We retrieved a total of 766
papers for further study. These papers were stud-
ied, and we selected the ones which met inclusion
criteria (see below).
Second, we conducted additional searches in
computerized literature databases in which we
combined search terms indicative of subthreshold
(subthreshold OR subclinical OR minor OR mild),
depression (major depression, depression, depres-
sive), and randomized controlled trial (randomized
OR randomised OR clinical OR trial OR experi-
mental). Both key words and text words were used.
For these additional searches we examined a total
of 1309 abstracts from the Cochrane database
(1047), Pubmed (205) and Psychinfo (57). Third,
references of reviews of minor depression and other
related subjects were examined (20–25). Fourth,
the references of retrieved papers were studied.
We included studies in which (1) a psychological
intervention (2) was compared to a control condi-
tion (3) in subjects with clinically relevant depressive
symptoms, (4) but no major depressive disorder or
dysthymia, (5) as established with help of a stan-
dardized diagnostic interview (such as the DISC,
CIDI, or SCAN) to exclude the presence of full-
blown mood disorder at pretest. Clinically relevant
depressive symptoms are deﬁned as scoring above a
cut-oﬀ score of a self-rating depression question-
naire; scoring above a cut-oﬀ score on a clinician-
rated instrument; or meeting criteria for minor
depression according to the criteria described in the
DSM, ICD, or Research Diagnostic Criteria.
We also included studies in which subjects with a
depressive disorder were included, but stratiﬁed
during randomization and the results speciﬁcally
reported for subjects with subthreshold depression.
No language restrictions or age limits were applied.
Description of included studies
Our literature search resulted in 86 randomized
studies in which a psychological intervention was
compared to a control condition. Of these 86 trials,
seven were aimed at subjects with clinically rele-
vant depressive symptoms, but no major depressive
disorder or dysthymia. These seven studies were
included in this meta-analysis. Selected character-
istics are presented in Table 1 (26–32). The studies
examined a total of 700 subjects, with 343 subjects
in the experimental conditions, and 357 in the
control conditions. The number of subjects per
study varied from 24 to 216.
In ﬁve of the seven studies, cognitive behaviour
therapy was used as a psychological intervention.
In all of these studies, an adaptation of the Coping
with Depression course was used, which is a
psycho-educational intervention in which several
mood management techniques are taught to the
patient (33), and which has been found to be
eﬀective as a treatment for major depression in
several studies (34). In the two studies which did
not use the Coping with Depression course,
problem solving therapy (30), and interpersonal
counseling (31) were used. The drop-out from the
interventions ranged from 13% to 37%.
Most studies (n ¼ 6) used care-as-usual as the
control condition. Two studies were aimed at
adolescents, three at adults, and two at elderly.
The diagnostic instruments used to exclude sub-
jects meeting diagnostic criteria for mood disorders
included the CIDI (two studies), the K-SADS (two
studies), the MINI, the SCID, and the DIS. In four
studies, longer term follow-up measures
(12 months post-test) were administered (26–28,
32). In these four studies, the incidence of major
depressive was assessed using standardized diag-
nostic interviews (the K-SADS, or the CIDI;
Table 1). All studies were conducted in the
United States (four studies) or the Netherlands
(three studies).
The quality of all studies was high. All used
randomized controlled designs, well-validated
measurement instruments, well-described and the-
oretically well-founded interventions, and
adequate statistical analyses.
Analyses
We conducted separate analyses for the eﬀects of
the interventions on depressive symptomatology
and for the eﬀects on the incidence of major
depressive disorder.
Effects on depressive symptomatology.
We calculated eﬀect sizes (d) by subtracting (at
post-test) the average score of the control group
(Me) from the average score of the experimental
group (Mc) and dividing the result by the pooled
standard deviations of the experimental and con-
trol group (SDec). An effect size of 0.5 thus
indicates that the mean of the experimental group
is half a standard deviation larger than the mean of
the control group. Effect sizes of 0.56–1.2 can be
assumed to be large, while effect sizes of 0.33–0.55
are moderate, and effect sizes of 0–0.32 are small
(35). In the calculations of eﬀect sizes, only those
instruments were used that explicitly measure
depression (Table 1). If more than one depression
measure was used, the mean of the eﬀect sizes was
calculated, so that each study (or contrast group)
had only one eﬀect size. When means and standard
Cuijpers et al.
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deviations were not reported, we used other
statistics (t-value, P-value) to calculate eﬀect sizes.
To calculate pooled mean eﬀect sizes, we used
the computer program Comprehensive Meta-ana-
lysis (version 2.2.021), developed for support in
meta-analysis. We conducted all analyses using
both the ﬁxed eﬀects model and the random eﬀects
model (36). Because the resulting eﬀect sizes were
comparable, and heterogeneity was low, we report
all results of the ﬁxed eﬀects model. As an
indicator of homogeneity, we calculated the Q-
statistic. We also calculated the I2-statistic which is
also an indicator of heterogeneity in percentages.
A value of 0% indicates no observed heterogeneity,
and larger values show increasing heterogeneity,
with 25% as low, 50% as moderate, and 75% as
high heterogeneity.
Effects on incidence of major depression.
Because the follow-up period of the studies diﬀered
considerably, we based the calculation of the
incidence rates on person-years. That is, we divided
the number of new cases of mental disorder that
occurred in the time period (the numerator) by the
total amount of person-time units (person-years) of
the group at risk (the denominator). Technically,
this is known as the person-time incidence rate, or
the incidence density rate. The person-time inci-
dence rate is an appropriate measure of incidence
when follow-up times are unequal (37). For each
study, we calculated the incident rate ratio (IRR)
of getting a major depressive disorder in experi-
mental subjects compared to the risk in control
subjects.
In the meta-analyses, we ﬁrst calculated overall
relative risks with the DerSimonian and Laird
method (38). Again, we conducted all meta-analy-
ses both with the ﬁxed eﬀects model and with the
random eﬀects model (36). And again, the resulting
relative risks were comparable for the two models.
As heterogeneity was low, we report the results of
the ﬁxed eﬀects model. For the analyses, we also
used the computer program Comprehensive Meta-
analysis (version 2.2.021). In addition, we calcula-
ted the Q-statistic and the I2-statistic to estimate
heterogeneity between study outcomes.
Publication bias was addressed by inspection of
the funnel plot on the primary outcome measures
(eﬀects on depressive symptomatology at post-test,
and eﬀects on the incidence of major depression),
and by Duval and Tweedie’s trim and ﬁll proce-
dure, which provides an estimate of the eﬀect size
after the publication bias has been taken into
account (as implemented in Comprehensive Meta-
analysis, version 2.2.021).
Results
Effects on depressive symptomatology
We could compare the eﬀects of the psychological
treatments to a control group at post-test in six
studies (Table 2). The mean eﬀect size was 0.42
(95% CI: 0.23–0.60), and was exactly the same in
the random eﬀects model and the ﬁxed eﬀects
model. We have plotted the eﬀect sizes and 95%
conﬁdence intervals of the individual contrast
groups in Fig. 1. The Q-statistic was 14.7 (df ¼ 5;
P ¼ 0.92), and the I2-statistic indicated a hetero-
geneity of 0%.
Over time the eﬀects became smaller. The eﬀects
of psychological treatments at 6-month follow-up
could be compared to care-as-usual in two studies.
The mean eﬀect size was 0.17 (95% CI: )0.11–
0.45), which was not signiﬁcant, while heterogen-
eity was moderate (I2 ¼ 48.2%). At 1-year follow-
up, four comparisons were available, resulting in a
mean effect size of 0.16 (95% CI: )0.02–0.35). This
was not signiﬁcant at the P < 0.05 level, but there
was a trend (P ¼ 0.08) indicating that psychologi-
cal treatment resulted in a reduction in depressive
symptomatology. Again heterogeneity was very
low (I2 ¼ 0%).
Effects on the incidence of major depressive disorder
We were able to examine the eﬀects of psycholo-
gical treatments on the incidence of new cases of
depressive disorders in four studies. The IRR of
developing a major depressive disorder in subjects
who received the intervention was 0.70 (95% CI:
0.47–1.03), compared with subjects in the control
condition. This was not signiﬁcant at the P < 0.05
level, but there was a trend (P ¼ 0.07) indicating
that the risk of getting major depression was lower
in the intervention condition. Again, the resulting
IRR was exactly the same when we used the
random eﬀects model and the ﬁxed eﬀects model.
We have plotted the IRRs and 95% conﬁdence
intervals of the individual contrast groups in
Table 2. Meta-analyses of studies examining the effects of psychological treat-
ments of subthreshold depression on depressive symptomatology, compared with
control conditions
ncomp n d 95% CI Q I
2 (%)
post-test 6 469 0.42** 0.230.60 1.44 n.s. 0
6-month follow-up 2 227 0.17 n.s. )0.110.45 1.93 n.s. 48.2
1-year follow-up 4 533 0.16 o )0.020.35 0.105 n.s. 0
Allart (26); Clarke et al. (28).
Allart (26); Clarke et al. (27); Clarke et al. (28); Willemse et al. (32).
o: P < 0.1; **P < 0.01.
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Fig. 2. Again, heterogeneity was very low. The Q-
statistic was 2.69 (df ¼ 3; P ¼ 0.44), and the I2-
statistic indicated a percentage of 0.
Publication bias
The funnel plots nor Duval and Tweedie’s trim and
ﬁll procedure pointed at a signiﬁcant publication
bias. The eﬀect size indicating the diﬀerence in
depressive symptomatology between experimental
and control conditions did not change signiﬁcantly
after adjustment for possible publication bias
(observed d ¼ 0.42; 95% CI: 0.23–0.60; adjusted
d ¼ 0.41 95% CI: 0.23–0.59; both with the ﬁxed
eﬀects model).
The observed IRR indicating the diﬀerence in
incidence of major depression between experimen-
tal and control condition (IRR ¼ 0.70; 95% CI:
0.47–1.03) did not diﬀer signiﬁcantly from the
adjusted IRR (0.62; 95% CI: 0.43–0.88) either.
Discussion
Our review gives clear indications that psychologi-
cal treatments for subthreshold depression have a
signiﬁcant eﬀect on depression in the short term.
The eﬀect size we found (d ¼ 0.42) is in the
moderate range. However, larger eﬀect sizes
cannot be expected in this population, because
the level of depressive symptomatology is already
relatively low in these subjects compared to sub-
jects with major depression, and therefore the
possibilities for improvement are limited.
With regard to the longer term, we did ﬁnd
indications that psychological interventions have
some eﬀects. Although the eﬀect size at 1-year
follow-up was small (d ¼ 0.16), there was a trend
indicating superiority of psychological treatment
compared with care-as-usual.
Although the eﬀects on depressive symptoma-
tology in the longer term were limited, we did ﬁnd
some signs that psychological interventions in
subthreshold depression may reduce the incidence
of major depression. We did not ﬁnd a signiﬁcant
eﬀect, but we did ﬁnd a trend indicating reduced
incidence. In these analyses, we used a two-sided
test. Because care-as-usual was used as control
condition in these studies, it could be argued that a
one-sided test should have been used (32) in which
case our results would have been signiﬁcant. And
because the number of included studies is small, we
consider this to be a promising result.
Another important ﬁnding of this study is that
virtually no heterogeneity between studies could be
found. Although this ﬁnding has to be considered
with caution because the number of studies is
small, it can be seen as an indication that our
results are robust. The psychological treatments in
Risk Lower Upper 
ratio limit limit Z-value P-value
Clarke, 1995 0.401 0.175 0.918 –2.163 0.031
Clarke, 2001 0.796 0.337 1.881 –0.519 0.604
Allart, 2003 1.033 0.456 2.341 0.078 0.938
Willemse, 2004 0.705 0.352 1.408 –0.991 0.322
0.695 0.468 1.033 –1.801 0.072
0.01 0.1 1 10 100
Favours treatment Favours control
Meta analysis
Incidence rate ratios and 95% CIStatistics for each studyStudy name
Fig. 2. Incidence rate ratios and 95%
conﬁdence intervals of studies examin-
ing the effects of psychological treat-
ments of subthreshold depression on
the incidence of new cases of major
depression.
Model Study name Statistics for each study Std diff in means 
and 95% CI
Std diff Lower Upper 
in means limit limit
Allart, 2003 0.574 0.170 0.978
Clarke, 2001 0.383 –0.034 0.800
Clarke, 1995 0.314 –0.041 0.669
Haringsma, 2005 0.299 –0.184 0.782
Lynch, 1997 0.630 –0.382 1.642
Mossey, 1996 0.510 0.028 0.992
Fixed 0.419 0.234 0.603
–2.00 –1.00 0.00 1.00 2.00
Favours control Favours treatment
Meta analysis
Fig. 1. Results of the post-test meta-
analysis of studies examining the effects
of psychological treatments for sub-
threshold depression on depressive
symptomatology, compared to control
conditions.
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these studies seem to have comparable eﬀects, and
the diﬀerences between the studies and the target
population do not seem to result in diﬀerential
eﬀects.
This study has several limitations. First, the
number of studies which satisﬁed all our inclusion
criteria, is small. Second, several basic elements of
included studies diﬀer from each other, including
diﬀerent target groups, diﬀerent measures, and
diﬀerent interventions. On the other hand, the low
heterogeneity can be seen as an indication that the
studies are comparable.
The studies also used diﬀerent deﬁnitions of
subthreshold depression. Most of them used a self-
rating scale to assess the presence of clinically
relevant depressive symptoms. It is not clear what
the clinical status is of subjects that score highly on
a self-rating scale but do not meet the criteria for a
depressive disorder. However, because the subjects
were willing to participate in the intervention, it
may be assumed that the symptoms were severe
enough to motivate participation.
For future research, it is important that clear
criteria are developed for subthreshold depressive
symptoms which are clinically relevant. Minor
depression, as deﬁned in the Appendix of the
DSM-IV, is an important step forward in this
respect, although not all subjects with clinically
relevant depressive symptoms will meet the criteria
for minor depression.
The studies also diﬀered in the type of treatment
that was used. However, most of them used a brief
version of the Coping with Depression course
(33). This intervention is attractive for this popu-
lation, because it is an evidence-based psycho-
educational intervention, which can be easily
adapted to the needs of speciﬁc populations. An
earlier meta-analysis of the Coping with Depres-
sion course showed that this intervention is an
eﬀective psychological treatment for established
depressive disorders (34), with eﬀect sizes which are
comparable with those of other psychological and
pharmacological treatments.
It has been suggested that antidepressant medi-
cation should be used to treat subthreshold depres-
sion (39). However, the evidence supporting anti-
depressants as a treatment in this population is
limited, and it is questionable whether patients will
consider medication to be an acceptable solution
(40). Brief psycho-educational interventions based
on cognitive behaviour therapy, however, seem to be
a more appropriate option for these problems.
This study does not allow to draw any conclu-
sions about the concept of subthreshold depres-
sion. However, it is reasonable to conclude that the
lower incidence of post-intervention major depres-
sive disorders found is compatible with perspec-
tives that view subthreshold depression as on a
continuum from no symptoms to major depres-
sion, or as a prodromal or residual phase of major
depression with the potential to increase risk of
new onset or recurrent episodes.
Despite the limitations of this meta-analysis, we
did ﬁnd clear indications that psychological ther-
apies are eﬀective in the treatment of subthreshold
depression. However, more research in this area is
clearly needed, as the deﬁnitions of subthreshold
depression still vary considerably, the target pop-
ulations have not been deﬁned consistently, and
the number of randomized trials examining the
interventions is still very limited.
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